KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Inventory Average (2016 - 2025)

Historic Inventory Average for Vertex Pharmaceuticals (VRTX) over the last 15 years, with Q3 2025 value amounting to $1.6 billion.

  • Vertex Pharmaceuticals' Inventory Average rose 5674.39% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 5674.39%. This contributed to the annual value of $972.1 million for FY2024, which is 6209.77% up from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Inventory Average of $1.6 billion as of Q3 2025, which was up 5674.39% from $1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Inventory Average peaked at $1.6 billion during Q3 2025, and registered a low of $289.8 million during Q1 2021.
  • For the 5-year period, Vertex Pharmaceuticals' Inventory Average averaged around $697.6 million, with its median value being $569.3 million (2023).
  • As far as peak fluctuations go, Vertex Pharmaceuticals' Inventory Average soared by 1387.9% in 2022, and later surged by 7094.85% in 2023.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Inventory Average stood at $343.3 million in 2021, then rose by 23.63% to $424.4 million in 2022, then soared by 68.18% to $713.8 million in 2023, then soared by 60.08% to $1.1 billion in 2024, then surged by 36.8% to $1.6 billion in 2025.
  • Its Inventory Average was $1.6 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $1.3 billion in Q1 2025.